eXoZymes, Inc. (EXOZ)
5.54
+0.02
(+0.36%)
USD |
NASDAQ |
Oct 07, 16:00
5.53
-0.01
(-0.18%)
After-Hours: 20:00
eXoZymes Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.83% |
| Date | Value |
|---|---|
| December 31, 2022 | -50.70% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Agenus, Inc. | 98.50% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Amgen, Inc. | 72.08% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -240.5% |
| Return on Assets | -144.1% |
| Return on Invested Capital | -186.0% |
| Return on Net Operating Assets | -530.1% |